Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
3.63%Cost of Revenue Margin
VS
Market
Sector
Industry
History
$ 5.93Close
$ 3.54 - $ 14.85 52-Week Range
Ticker Information
Ticker
KPTICompany Name
KARYOPHARM THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQKARYOPHARM THERAPEUTICS INC - Cost of Revenue Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
KPTI - COGS % Historical data
| Date | Cost of Revenue | Cost of Revenue Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 4.98M | 3.63% | $ 137.27M |
| 3/31/2025 | $ 5.4M | 3.8% | $ 142.13M |
| 12/31/2024 | $ 6.01M | 4.14% | $ 145.24M |
| 9/30/2024 | $ 6.16M | 4.15% | $ 148.44M |
| 6/30/2024 | $ 5.77M | 3.96% | $ 145.67M |
| 3/31/2024 | $ 5.5M | 3.92% | $ 140.46M |
| 12/31/2023 | $ 4.94M | 3.38% | $ 146.03M |
| 9/30/2023 | $ 5.32M | 3.65% | $ 145.87M |
| 6/30/2023 | $ 5.39M | 3.69% | $ 146M |
| 3/31/2023 | $ 5.14M | 3.47% | $ 148.1M |
Key Performance Insights, Last 5 Years
- KARYOPHARM THERAPEUTICS INC's latest trailing twelve months (TTM) COGS % stands at 3.35%.
- Over the past 5 years, KARYOPHARM THERAPEUTICS INC's average COGS % has been 3.12%.
- The median COGS % for KARYOPHARM THERAPEUTICS INC during this period was 3.43%
- KARYOPHARM THERAPEUTICS INC reached its highest COGS % over the past 5 years at 4.15%.
- The lowest COGS % recorded by KARYOPHARM THERAPEUTICS INC in the same timeframe 1.47%
KARYOPHARM THERAPEUTICS INC's COGS % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
COGS % Benchmarks
Similar metrics to Revenues:
- Cost of Revenue - [Income Statement] The cost of revenue is the total amount paid to produce and sell a product or service and can be found in the income statement.
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
Definition of Cost of Revenue Margin
[Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.COGS / Revenues
(=) COGS % COGS % for KARYOPHARM THERAPEUTICS INC is calculated as follows: COGS [ $ 3.05M ] / Revenues [ $ 91.08M ]
(=) COGS % [ 3.35% ] KPTI - Cost of Revenue Margin, Last 5 years
1.47%
Minimum
Jun 30, 2022
4.15%
Maximum
Sep 30, 2024
3.12%
Average
3.43%
Median
COGS % Benchmark AnalysisMarket
The chart above depicts the distribution of COGS % for companies in the Total Stock Market. The average COGS % of the companies is 46.91% with a standard deviation of 31.59%.
The following table provides additional summary stats:
COGS % in the Market:
| filtered constituents | 3.81K |
|---|---|
| min | -50.26% |
| max | 172.25% |
| average | 46.91% |
| median | 50.54% |
| std | 31.59% |